KINGDON CAPITAL MANAGEMENT, L.L.C. - AVALANCHE BIOTECHNOLOGIES IN ownership

AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 113 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of AVALANCHE BIOTECHNOLOGIES IN
ValueSharesWeighting
Q2 2015$2,274,000
-82.2%
140,000
-55.6%
0.09%
-83.6%
Q1 2015$12,779,000315,3800.54%
Other shareholders

There were no reported owners of AVALANCHE BIOTECHNOLOGIES IN in Q1 2015.

NameSharesValueWeighting ↓
View complete list of AVALANCHE BIOTECHNOLOGIES IN shareholders